Meet
Features
Solutions
Pricing
Sales Intelligence
Qualify prospects and connect with decision makers effortlessly
Research Companies & Directors
Make important decisions with absolute confidence
Create B2B Marketing Lists
Target and reach more of your ideal prospects than ever
Monitor Risks & Opportunities
Be the first to learn about changes in the companies that matter
Cleanse Your B2B Database
Instantly transform old records into new opportunities
Perform KYC Checks
Completely understand who you're working with
Discover New Businesses
Identify and connect with new companies as soon as they register
Company Credit Reports
See how companies are performing year–on–year and explore their debts
UPGRADE
Contact
Credit Report
Financials
People
Ownership
Latest Activity
Mutual Companies
Documents
Repayment History
Enedra Therapeutics Limited
Enedra Therapeutics Limited is an active company incorporated on 2 June 2021 with the registered office located in Cambridge, Cambridgeshire. Enedra Therapeutics Limited was registered 4 years ago.
Watch Company
Status
Active
Active since
incorporation
Company No
13433538
Private limited company
Age
4 years
Incorporated
2 June 2021
Size
Micro
Turnover is under
£1M
Balance sheet is under
£500,000
Under
10 employees
Confirmation
Submitted
Dated
1 June 2025
(5 months ago)
Next confirmation dated
1 June 2026
Due by
15 June 2026
(7 months remaining)
Last change occurred
4 months ago
Accounts
Submitted
For period
1 Nov
⟶
31 Jul 2025
(9 months)
Accounts type is
Total Exemption Full
Next accounts for period
31 July 2026
Due by
30 April 2027
(1 year 5 months remaining)
Learn more about Enedra Therapeutics Limited
Contact
Update Details
Address
Salisbury House
Station Road
Cambridge
CB1 2LA
England
Address changed on
3 Nov 2022
(3 years ago)
Previous address was
46-54 High Street Ingatestone Essex CM4 9DW United Kingdom
Companies in CB1 2LA
Telephone
Unreported
Email
Unreported
Website
Enedratx.com
See All Contacts
People
Officers
7
Shareholders
10
Controllers (PSC)
1
Mr Andreas Ballis
PSC • Director • Greek • Lives in UK • Born in Jul 1978
Keith Stuart Blundy
Director • British • Lives in England • Born in Apr 1960
Dr Adrian Paul Ibrahim
Director • British • Lives in England • Born in May 1971
Tanya Marie Moore
Director • British • Lives in UK • Born in May 1975
Dr Kerstin Papenfuss
Director • Scientist • German • Lives in UK • Born in May 1982
See Key People
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
See All Shareholders, PSCs & Group Structure
Mutual Companies
Neobe Therapeutics Ltd
Dr Laura Margaret Fletcher and Keith Stuart Blundy are mutual people.
Active
Antiverse Ltd
Dr Kerstin Papenfuss is a mutual person.
Active
NK:Io Ltd
Tanya Marie Moore is a mutual person.
Active
Stratosvir Limited
Dr Laura Margaret Fletcher is a mutual person.
Active
Plurify Ltd
Dr Kerstin Papenfuss is a mutual person.
Active
Panthura Ltd
Dr Kerstin Papenfuss is a mutual person.
Active
A.T. Bio Limited
Dr Adrian Paul Ibrahim is a mutual person.
Active
Cureage Therapeutics Ltd
Dr Kerstin Papenfuss is a mutual person.
Active
See All Mutual Companies
Financials
Net Assets, Total Assets & Total Liabilities (2022–2025)
Period Ended
31 Jul 2025
For period
31 Oct
⟶
31 Jul 2025
Traded for
9 months
Cash in Bank
£37.17K
Decreased by £53.2K (-59%)
Turnover
Unreported
Same as previous period
Employees
6
Increased by 2 (+50%)
Total Assets
£408.5K
Decreased by £285.22K (-41%)
Total Liabilities
-£20.16K
Decreased by £618.86K (-97%)
Net Assets
£388.33K
Increased by £333.64K (+610%)
Debt Ratio (%)
5%
Decreased by 87.18% (-95%)
See 10 Year Full Financials
Latest Activity
Full Accounts Submitted
2 Months Ago on 5 Sep 2025
Accounting Period Shortened
2 Months Ago on 4 Sep 2025
Dr Adrian Paul Ibrahim Appointed
2 Months Ago on 4 Sep 2025
Full Accounts Submitted
4 Months Ago on 4 Jul 2025
Confirmation Submitted
4 Months Ago on 23 Jun 2025
Kerstin Papenfuss Resigned
11 Months Ago on 30 Nov 2024
Patrick Christian Maurice Chaltin Appointed
1 Year Ago on 6 Nov 2024
Dr Kerstin Papenfuss Appointed
1 Year Ago on 29 Oct 2024
Compulsory Strike-Off Discontinued
1 Year 2 Months Ago on 24 Aug 2024
Confirmation Submitted
1 Year 2 Months Ago on 21 Aug 2024
Get Alerts
Get Credit Report
Discover Enedra Therapeutics Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
See All Credit Score & Limits
Documents
Total exemption full accounts made up to 31 July 2025
Submitted on 5 Sep 2025
Previous accounting period shortened from 31 October 2025 to 31 July 2025
Submitted on 4 Sep 2025
Appointment of Dr Adrian Paul Ibrahim as a director on 4 September 2025
Submitted on 4 Sep 2025
Total exemption full accounts made up to 31 October 2024
Submitted on 4 Jul 2025
Confirmation statement made on 1 June 2025 with updates
Submitted on 23 Jun 2025
Resolutions
Submitted on 20 Dec 2024
Appointment of Dr Kerstin Papenfuss as a director on 29 October 2024
Submitted on 16 Dec 2024
Termination of appointment of Kerstin Papenfuss as a director on 30 November 2024
Submitted on 16 Dec 2024
Statement of capital following an allotment of shares on 15 November 2024
Submitted on 25 Nov 2024
Appointment of Patrick Christian Maurice Chaltin as a director on 6 November 2024
Submitted on 12 Nov 2024
Explore All Documents
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year
See All Charges & CCJs